Endocrinology, Diabetes & Metabolism Doctors in Middletown, NY Accepting Medicare

7 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 7

Peggy Nelson, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999    Fax: 845-703-6297

Mr. Elliott Theodore Friedman, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 111 Maltese Dr, Middletown, NY 10940 Phone: 845-342-4774    Fax: 845-818-7555

Dr. Florence Intia Celzo-vista, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999    Fax: 845-703-6297

Quang V Ton, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999    Fax: 845-703-6297

Scott T Hines, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999    Fax: 845-703-6297

Kristen Hull, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999    Fax: 845-703-6297

Padma Raghavan Pillai, Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 111 Maltese Dr, Middletown, NY 10940 Phone: 845-342-4774

News Archive

Stimuvax investigational lung cancer vaccine phase III study starts

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

Breastfeeding could reduce risk of aggressive form of breast cancer that disproportionately affects black, younger women

Breastfeeding for at least six months might lower the risk of developing so-called "triple negative" breast cancer, an aggressive form of the disease that is more common in black and younger women, according to a study published on Monday in the journal Cancer, the Seattle Post-Intelligencer reports (Paulson, Seattle Post-Intelligencer, 8/24).

$2.8 billion U.S. peripheral vascular device market to grow to over $5.3 billion by 2016

According to a new report by iData Research, the leading authority in medical device and pharmaceutical market research, the U.S. peripheral vascular device market is worth $2.8 billion with expected growth to over $5.3 billion by 2016. Increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD) are the main drivers of this market, particularly in the stent-graft and peripheral vascular stent segments. These markets are both expected to exceed $1 billion by 2016.

Sudden cardiac death number one risk for patients on dialysis

In a 10-year study of more than a thousand kidney failure patients, sudden cardiac death emerged as the number one cause of death for patients on dialysis, according to a Johns Hopkins researcher. The study, already published online and appearing in the Nov. 2 issue of Kidney International, identified systemic inflammatory response and malnutrition as key risk factors for the fatal heart attacks.

Read more Medical News

› Verified 8 days ago